TNYA Tenaya Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 5, 2026 10-K/10-Q 八月 5, 2026TNYA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
TNYA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
| 指标 | 5年趋势 | TNYA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -1.05年均值 ≈-1.9 | ≈-1.9 | · | · | |
| 市净率 (MRQ) | 1.85年均值 ≈1.5 | ≈1.5 | 2.1 | 公允价值 | |
| 股价/自由现金流 (TTM) | -2.45年均值 ≈-3.2 | ≈-3.2 | · | · | |
| 市现率 (TTM) | -2.45年均值 ≈-4.0 | ≈-4.0 | · | · | |
| Price / Tangible Book (市净率(有形资产)) | 1.05年均值 ≈1.5 | ≈1.5 | · | · |
同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | TNYA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -67.9%5年均值 ≈-54.6% | ≈-54.6% | -73.6% | 持平 | |
| ROE | -81.2%5年均值 ≈-70.4% | ≈-70.4% | -108.3% | 顶尖 | |
| ROIC | -75.7%5年均值 ≈-74.5% | ≈-74.5% | -75.7% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | TNYA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 4.55年均值 ≈7.1 | ≈7.1 | 4.8 | 持平 | |
| Quick Ratio (速动比率) | 6.55年均值 ≈6.8 | ≈6.8 | 3.7 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
基本面数据不足,尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
基本面数据不足,尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-0.20 | $-0.07 | -186.9% |
| 2026年3月31日 | 五月 13, 2026 | $-0.09 | $-0.09 | -1.2% |
| 2025年12月31日 | $-0.12 | $-0.12 | 3.0% | |
| 2025年9月30日 | $-0.12 | $-0.15 | 20.4% | |
| 2025年6月30日 | $-0.14 | $-0.26 | 45.1% | |
| 2025年3月31日 | $-0.24 | $-0.19 | -23.8% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $69M | $87M | $98M | $95M | $54M | $31M | |
| SG&A Expense | $25M | $29M | $33M | $31M | $18M | $8M | |
| Operating Expenses | $93M | $116M | $131M | $126M | $73M | $39M | |
| Operating Income | $-93M | $-116M | $-131M | $-126M | $-73M | $-39M | |
| Interest Income | $3M | $5M | $7M | $2M | $108.0K | $87.0K | |
| Other Non-op | $52.0K | $82.0K | $53.0K | $2.0K | $-23.0K | $355.0K | |
| Pretax Income | $-91M | $-111M | $-124M | $-124M | $-73M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-91M | $-111M | $-124M | $-124M | $-73M | $-38M | |
| EPS (Basic) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · | |
| EPS (Diluted) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · | |
| Shares (Basic) | 152,971,259 | 84,822,468 | 73,786,126 | 44,823,597 | 17,734,166 | · | |
| Shares (Diluted) | 152,971,259 | 84,822,468 | 73,786,126 | 44,823,597 | 17,734,166 | · | |
| EBITDA | $-85M | $-107M | $-123M | $-119M | $-70M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $101M | $4M | $46M | $95M | $38M | $129M | |
| Short-term Investments | · | $57M | $59M | $91M | $213M | · | |
| Prepaid Expense | $5M | $6M | $7M | $7M | $4M | $1M | |
| Other Current Assets | $1M | $842.0K | $1M | $938.0K | · | · | |
| Current Assets | $106M | $67M | $112M | $194M | $255M | $130M | |
| PP&E (Net) | $28M | $36M | $43M | $51M | $43M | $17M | |
| PP&E (Gross) | $68M | $68M | $68M | $67M | $52M | $24M | |
| Accum. Depreciation | $40M | $32M | $24M | $16M | $9M | $7M | |
| Other Non-current Assets | $4M | $5M | $6M | $5M | $4M | $465.0K | |
| Total Assets | $147M | $120M | $171M | $279M | $314M | $148M | |
| Accounts Payable | $4M | $5M | $6M | $10M | $11M | $1M | |
| Accrued Liabilities | $9M | $8M | $13M | $11M | $9M | $3M | |
| Current Liabilities | $15M | $16M | $23M | $24M | $22M | $5M | |
| Capital Leases | $8M | $11M | $8M | $11M | $14M | · | |
| Other Non-current Liabilities | $410.0K | $281.0K | $253.0K | $228.0K | $182.0K | $19.0K | |
| Total Liabilities | $24M | $27M | $31M | $36M | $36M | $9M | |
| Common Stock | $21.0K | $8.0K | $7.0K | $7.0K | $4.0K | · | |
| Paid-in Capital | $728M | $607M | $543M | $523M | $434M | $2M | |
| Retained Earnings | $-605M | $-514M | $-403M | $-279M | $-156M | $-83M | |
| AOCI | $0 | $28.0K | $-106.0K | $-378.0K | $-141.0K | · | |
| Stockholders' Equity | $123M | $93M | $139M | $243M | $279M | $-81M | |
| Liabilities + Equity | $147M | $120M | $171M | $279M | $314M | $148M | |
| Shares Outstanding | 216,760,283 | 86,542,340 | 68,330,342 | 66,857,113 | 41,291,374 | 1,210,306 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $6M | $3M | $2M | |
| Stock-based Comp | $13M | $17M | $15M | $11M | $3M | $741.0K | |
| Other Non-cash | $851.0K | $-4M | $-2M | $1M | $6M | · | |
| Operating Cash Flow | $-68M | $-91M | $-102M | $-104M | $-61M | $-35M | |
| CapEx | $618.0K | $1M | $1M | $21M | $25M | $10M | |
| Investing Cash Flow | $56M | $1M | $49M | $84M | $-239M | $-7M | |
| Stock Issued | · | · | $4M | · | · | · | |
| Stock Repurchased | · | · | · | · | $13.0K | $1.0K | |
| Net Stock Activity | · | · | $4M | · | $-13.0K | · | |
| Financing Cash Flow | $108M | $48M | $4M | $78M | $209M | $147M | |
| Net Change in Cash | $96M | $-42M | $-49M | $57M | $-90M | $105M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-69M | $-92M | $-103M | $-125M | $-86M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.9% | -76.5% | -55.2% | -41.7% | -31.5% | · | |
| ROE | -81.2% | -108.2% | -81.5% | -56.2% | -25.0% | · | |
| ROIC | -75.7% | -124.9% | -94.1% | -51.6% | -26.1% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | 4.2 | 4.9 | 8.0 | 11.7 | · | |
| Quick Ratio | 6.5 | 3.8 | 4.6 | 7.7 | 11.5 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.57 | $1.07 | $2.04 | $3.64 | $6.75 | · | |
| Cash Flow / Share | $-0.45 | $-1.07 | $-1.38 | $-2.33 | · | · | |
| Cash / Share | $0.46 | $0.05 | $0.67 | $1.43 | $0.92 | · | |
| EPS (TTM) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-111M | $-124M | $-124M | $-73M | · | |
| Market Cap | $154M | $124M | $221M | $134M | $782M | · | |
| P/E | -1.2 | -1.1 | -1.9 | -0.7 | -4.6 | · | |
| P/B | 1.3 | 1.3 | 1.6 | 0.6 | 2.8 | · | |
| P / Tangible Book | 1.3 | 1.3 | 1.6 | 0.6 | 2.8 | · | |
| P / Cash Flow | -2.3 | -1.4 | -2.2 | -1.3 | -12.9 | · | |
| P / FCF | -2.2 | -1.4 | -2.1 | -1.1 | -9.1 | · | |
| Earnings Yield | -82.9% | -91.6% | -51.8% | -137.3% | -21.6% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $1M | $225.0K | · | · | $0 | $0 | |
| R&D Expense | $17M | $15M | $15M | $15M | $17M | $21M | |
| SG&A Expense | $5M | $5M | $6M | $6M | $7M | $6M | |
| Operating Expenses | $45M | $20M | $21M | $21M | $24M | $28M | |
| Operating Income | $-44M | $-20M | $-21M | $-21M | $-24M | $-28M | |
| Interest Income | $697.0K | $793.0K | $574.0K | $658.0K | $815.0K | $635.0K | |
| Other Non-op | $-2.0K | · | $26.0K | $3.0K | $-16.0K | $39.0K | |
| Pretax Income | $-43M | $-19M | $-20M | $-20M | $-23M | $-27M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-43M | $-19M | $-20M | $-20M | $-23M | $-27M | |
| EPS (Basic) | $-0.20 | $-0.09 | $-0.09 | $-0.12 | $-0.14 | $-0.24 | |
| EPS (Diluted) | $-0.20 | $-0.09 | $-0.09 | $-0.12 | $-0.14 | $-0.24 | |
| Shares (Basic) | 217,574,637 | 216,883,164 | · | 163,345,972 | 162,791,579 | 109,869,278 | |
| Shares (Diluted) | 217,574,637 | 216,883,164 | · | 163,345,972 | 162,791,579 | 109,869,278 | |
| EBITDA | $-44M | $-18M | · | $-21M | $-24M | $-25M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $81M | $101M | $56M | $63M | $54M | |
| Short-term Investments | · | · | · | · | $9M | $34M | |
| Receivables | $371.0K | $11M | · | · | · | · | |
| Prepaid Expense | $8M | $5M | $5M | $5M | $4M | $6M | |
| Other Current Assets | $4M | $25.0K | $1M | $990.0K | $218.0K | $1M | |
| Current Assets | $86M | $97M | $106M | $61M | $76M | $94M | |
| PP&E (Net) | $2M | $26M | $28M | $29M | $31M | $33M | |
| PP&E (Gross) | $27M | $68M | $68M | $68M | $68M | $68M | |
| Accum. Depreciation | $25M | $42M | $40M | $39M | $37M | $35M | |
| Other Non-current Assets | $2M | $4M | $4M | $4M | $4M | $5M | |
| Total Assets | $94M | $135M | $147M | $105M | $122M | $144M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $5M | |
| Accrued Liabilities | $8M | $6M | $9M | $7M | $7M | $6M | |
| Current Liabilities | $19M | $17M | $15M | $13M | $13M | $14M | |
| Capital Leases | $1M | $7M | $8M | $9M | $9M | $10M | |
| Other Non-current Liabilities | $103.0K | $418.0K | $410.0K | $301.0K | $293.0K | $287.0K | |
| Total Liabilities | $24M | $29M | $24M | $22M | $22M | $25M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $16.0K | $16.0K | $16.0K | |
| Paid-in Capital | $737M | $730M | $728M | $668M | $664M | $661M | |
| Retained Earnings | $-668M | $-624M | $-605M | $-585M | $-565M | $-541M | |
| AOCI | · | · | $0 | · | $-1.0K | $-10.0K | |
| Stockholders' Equity | $69M | $106M | $123M | $83M | $100M | $119M | |
| Liabilities + Equity | $94M | $135M | $147M | $105M | $122M | $144M | |
| Shares Outstanding | 224,230,012 | 216,998,876 | 216,760,283 | · | · | · |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $2M | $2M | $3M | $3M | $4M | $4M | |
| Other Non-cash | · | $-4M | · | · | · | $-3M | |
| Operating Cash Flow | $-4M | $-19M | $-14M | $-16M | $-16M | $-23M | |
| CapEx | $159.0K | $11.0K | $67.0K | $26.0K | $142.0K | $383.0K | |
| Investing Cash Flow | $-159.0K | $-11.0K | $-67.0K | $9M | $25M | $22M | |
| Financing Cash Flow | $909.0K | $-415.0K | $58M | $380.0K | $-476.0K | $50M | |
| Net Change in Cash | $-3M | $-20M | $44M | $-6M | $9M | $49M | |
| Free Cash Flow | · | $-19M | · | · | · | $-23M |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3971.9% | -8917.8% | · | · | · | · | |
| Net Margin | -3909.3% | -8565.3% | · | · | · | · | |
| Pretax Margin | -3909.3% | -8565.3% | · | · | · | · | |
| EBITDA Margin | -3971.9% | -8134.2% | · | · | · | · | |
| ROA | -40.2% | -13.8% | · | -16.5% | -16.3% | -16.3% | |
| ROE | -51.3% | -17.1% | · | -20.7% | -19.9% | -19.4% | |
| ROIC | -63.5% | -18.9% | · | · | · | -23.1% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 5.8 | · | 4.6 | 6.0 | 6.7 | |
| Quick Ratio | 4.1 | 5.5 | · | 4.3 | 5.7 | 6.2 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 6.0 | 0.0 | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.31 | $0.49 | · | · | · | · | |
| Revenue / Share | $0.01 | $0.00 | · | · | · | · | |
| Cash Flow / Share | · | $-0.09 | · | · | · | $-0.21 | |
| Cash / Share | $0.35 | $0.37 | · | · | · | · | |
| EPS (TTM) | $-0.50 | $-0.44 | · | $-0.77 | $-0.95 | $-1.15 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-103M | $-83M | · | $-94M | $-100M | $-106M | |
| Market Cap | $166M | $150M | · | · | · | · | |
| P/E | -1.5 | -1.6 | · | -2.1 | -0.6 | -0.5 | |
| P/B | 2.4 | 1.4 | · | · | · | · | |
| P / Tangible Book | 2.4 | 1.4 | · | · | · | · | |
| P / Cash Flow | · | -7.8 | · | · | · | · | |
| Earnings Yield | -67.7% | -63.6% | · | -47.5% | -155.5% | -201.8% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-91M | $-111M | $-124M | $-124M | $-73M |
| 稀释后每股收益 (EPS) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 6.8 | 4.2 | 4.9 | 8.0 | 11.7 |
| 速动比率 | 6.5 | 3.8 | 4.6 | 7.7 | 11.5 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-69M | $-92M | $-103M | $-125M | $-86M |
机构持有人 (13F) 113 家申报者 · $44.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 20 (-7 与上一季度对比) | 19 (+3 与上一季度对比) | 33 (-2 与上一季度对比) | 18 (-1 与上一季度对比) | -858K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6094797 | 8560108 | 13.77% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $5247833 | 7101263 | 11.86% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $4752153 | 6429648 | 10.74% | 股份 |
| CITADEL ADVISORS LLC | $3375303 | 4566774 | 7.63% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $3164161 | 4281100 | 7.15% | 股份 |
| BlackRock, Inc. | $2962845 | 4008719 | 6.69% | 股份 |
| Empery Asset Management, LP | $2855228 | 3863115 | 6.45% | 股份 |
| MARSHALL WACE, LLP | $2592352 | 3503178 | 5.86% | 股份 |
| Burkehill Global Management, LP | $1478200 | 2000000 | 3.34% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1356805 | 1834674 | 3.07% | 股份 |
| ADAR1 Capital Management, LLC | $1149670 | 1555500 | 2.60% | 股份 |
| Raiffeisen Bank International AG | $881880 | 1200000 | 1.99% | 股份 |
| Euclidean Capital LLC | $750708 | 1015705 | 1.70% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $729766 | 987505 | 1.65% | 股份 |
| Mirador Capital Partners LP | $668957 | 905097 | 1.51% | 股份 |
| STATE STREET CORP | $523816 | 708721 | 1.18% | 股份 |
| Squarepoint Ops LLC | $487249 | 659247 | 1.10% | 股份 |
| UBS Group AG | $337394 | 456555 | 0.76% | 股份 |
| JANE STREET GROUP, LLC | $332917 | 450435 | 0.75% | 股份 |
| StepStone Group LP | $318892 | 462163 | 0.72% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $281442 | 380790 | 0.64% | 股份 |
| TWO SIGMA ADVISERS, LP | $280687 | 394500 | 0.63% | 股份 |
| Casdin Capital, LLC | $267531 | 361969 | 0.60% | 股份 |
| Invesco Ltd. | $262279 | 354862 | 0.59% | 股份 |
| NORTHERN TRUST CORP | $256003 | 346371 | 0.58% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $240441 | 325316 | 0.54% | 股份 |
| XTX Topco Ltd | $231699 | 313488 | 0.52% | 股份 |
| DAFNA Capital Management LLC | $221730 | 300000 | 0.50% | 股份 |
| GOLDMAN SACHS GROUP INC | $217841 | 294739 | 0.49% | 股份 |
| Marex Group Ltd | $174058 | 235500 | 0.39% | 股份 |
| MORGAN STANLEY | $171688 | 232293 | 0.39% | 股份 |
| CITADEL ADVISORS LLC | $148485 | 200900 | 0.34% | 买入期权 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $143977 | 194800 | 0.33% | 股份 |
| Almanack Investment Partners, LLC. | $124317 | 168200 | 0.28% | 股份 |
| CITIGROUP INC | $68305 | 92417 | 0.15% | 股份 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $66310 | 76183 | 0.15% | 股份 |
| Pathstone Holdings, LLC | $55433 | 75000 | 0.13% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $54020 | 73000 | 0.12% | 买入期权 |
| DIMENSIONAL FUND ADVISORS LP | $47971 | 64904 | 0.11% | 股份 |
| Cetera Investment Advisers | $42221 | 57125 | 0.10% | 股份 |
| Vanguard Global Advisers, LLC | $37002 | 50070 | 0.08% | 股份 |
| Callan Family Office, LLC | $37000 | 50061 | 0.08% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32782 | 44300 | 0.07% | 卖出期权 |
| JANE STREET GROUP, LLC | $31633 | 42800 | 0.07% | 买入期权 |
| Point72 Asia (Singapore) Pte. Ltd. | $28447 | 17560 | 0.06% | 股份 |
| Spark Investment Management LLC | $26238 | 35500 | 0.06% | 股份 |
| Vanguard Personalized Indexing Management, LLC | $25773 | 34871 | 0.06% | 股份 |
| OSAIC HOLDINGS, INC. | $25576 | 34563 | 0.06% | 股份 |
| China Universal Asset Management Co., Ltd. | $25525 | 34535 | 0.06% | 股份 |
| H D Vest Advisory Services | $23531 | 38500 | 0.05% | 股份 |
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| The Column Group III, LP, The Column Group III-A, LP, The Column Group III GP, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson ×8 申报 | 2026年2月26日 | 23.10% | 修订 | · | SEC |
| Casdin Capital, LLC, Casdin Partners Master Fund, L.P., Casdin Partners GP, LLC, Eli Casdin ×4 申报 | 2025年3月7日 | 4.30% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 18 位内幕人士 · 7 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Faraz Ali | Chief Executive Officer | 2026年9月10日 A | 539782 | 0 | 9 | $-32132 |
| Eric J Hyllengren | Chief Financial Officer | 2026年7月13日 A | · | 0 | 0 | $0 |
| Whittemore Tingley | Chief Medical Officer | 2026年9月10日 A | 263073 | 0 | 9 | $-14865 |
| Tomohiro Higa | SVP, Finance | 2026年5月18日 S | 118267 | 0 | 5 | $-5211 |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | 2024年11月18日 S | 60983 | 0 | 0 | $0 |
| Timothy Hoey | Chief Scientific Officer | 2024年3月5日 S | 245346 | 0 | 0 | $0 |
| Leone D Patterson | Chief Fin. and Bus. Officer | 2024年2月23日 A | 95755 | 0 | 0 | $0 |
| Amy L. Burroughs | 董事 | 2026年5月28日 A | · | 0 | 0 | $0 |
| Deepak Srivastava | 董事 | 2026年5月28日 A | 372435 | 0 | 0 | $0 |
| Catherine Stehman-Breen | 董事 | 2026年5月28日 A | · | 0 | 0 | $0 |
| June Lee | 董事 | 2026年5月28日 A | · | 0 | 0 | $0 |
| Karah Herdman Parschauer | 董事 | 2026年5月28日 A | · | 0 | 0 | $0 |
| Jeffrey T. Walsh | 董事 | 2026年5月28日 A | · | 0 | 0 | $0 |
| Sanders R Williams | 董事 | 2026年5月28日 A | · | 0 | 0 | $0 |
| David V Goeddel | 董事 | 2025年5月29日 A | 49313559 | 0 | 0 | $0 |
| Jin-Long Chen | 董事 | 2023年6月9日 A | · | 0 | 0 | $0 |
| Eli Casdin | 董事 | 2022年6月10日 A | 361969 | 0 | 0 | $0 |
| Jeenjoo Kang | 董事 | 2021年8月3日 C | 25000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
ETF持仓 由 6 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.43% | 174387 SH | 2026年10月2日 | 每日 |
| IBB · iShares Trust | 0.01% | 1588805 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.01% | 15116 SH | 2026年10月2日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 298371 SH | 2026年10月2日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1768551 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 5136220 SH | 2026年8月19日 | 每日 |
TNYA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
12个月价格目标
5 位分析师 · 2026-10-05平均目标 $3.20 +469.9%
同行比较(GICS 子行业) 关键指标与行业同行对比
财年依据,价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| VTVT | · | · | · | · | -70.4% | · |
| HURA | · | -1.2 | · | · | · | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存,并会跟随您浏览所有股票。